Patents Assigned to Boehringer Ingelheim Pharma GmbH & Co. KG
-
Publication number: 20230226478Abstract: A cleaning method for sectional cleaning of a filter having several filter sections, the filter sections being cleaned within a cleaning cycle in cleaning processes separated in time from one another, the cleaning method having at least two cleaning cycles and both a time interval between the cleaning processes within the respective cleaning cycle and also a time interval between the end of one of the cleaning cycles and the start of a following one of the cleaning cycles being changed. Moreover, a connecting device for connecting a filter to a cleaning device having a side wall, which borders an internal cross section, which increases along a longitudinal axis of the connecting device and has lateral openings with assigned major axes and a method of connecting the connecting device to a filter device.Type: ApplicationFiled: February 9, 2023Publication date: July 20, 2023Applicant: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KGInventor: Rainer BAUER
-
Patent number: 10112019Abstract: An inhaler for use with a dry powder pharmaceutical formulation, including: a chamber containing the dry powder formulation, a valve disposed in series with the chamber for regulating air flow through the chamber, and a bypass coupled around the combination of the chamber and the valve, where the valve and bypass cooperate for ensuring that the air flow is at least essentially fixed or kept constant or at a minimum accepted or desired or required flow rate through the chamber, and for varying air flow restriction through the inhaler with flow rate, or for keeping the air flow restriction generally constant.Type: GrantFiled: February 2, 2009Date of Patent: October 30, 2018Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventor: Stephen T. Dunne
-
Publication number: 20180236386Abstract: A cleaning method for sectional cleaning of a filter is proposed, the filter having several filter sections, by means of one cleaning process one of the filter sections at a time being cleaned, the filter sections being cleaned within one cleaning cycle in cleaning processes separated in time from one another, the cleaning method having at least two cleaning cycles and both one time interval between the cleaning processes within the respective cleaning cycle and also one time interval between the end of one of the cleaning cycles and the start of a following one of the cleaning cycles being changed, and/or the filter having at least three filter sections, the filter sections being cleaned in cleaning processes separated by time intervals from one another and the time intervals between successive cleaning processes being changed.Type: ApplicationFiled: October 14, 2015Publication date: August 23, 2018Applicant: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KGInventor: Rainer BAUER
-
Patent number: 9604017Abstract: The invention relates to a powder inhaler with at least one specially sharpened needle, to ensure the precise piercing or cutting open of capsules and hence the optimum delivery of powdered medicament compositions, medicament formulations or medicament mixtures, as well as ensuring that little effort is needed to perforate or cut open the capsule.Type: GrantFiled: November 15, 2006Date of Patent: March 28, 2017Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventors: Hubert Hoelz, Stefan Lustenberger, Torsten Kuehn, Herbert Wachtel, Rolf Kuhn
-
Patent number: 9364841Abstract: An inhaler including a pre-inserted cartridge (100) is proposed. The cartridge contains liquid (103) which is preferably pressurized to a low pressure. The cartridge is connected via an aerosol valve (106) with the inhaler. The liquid is further pressurized by a pump (117) of the inhaler to a high pressure and atomized.Type: GrantFiled: February 18, 2009Date of Patent: June 14, 2016Assignee: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KGInventors: Stephen T. Dunne, Heinrich Kladders
-
Patent number: 9259540Abstract: A nozzle, an inhaler with a nozzle and a method for producing a nozzle are proposed, which nozzle comprises two holes formed in a flat plate which plate is then deformed such that the axes of the holes intersect so that jets of fluids moving through the holes impinge with each other.Type: GrantFiled: November 13, 2013Date of Patent: February 16, 2016Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventor: Stephen Terence Dunne
-
Patent number: 9156835Abstract: The invention relates to a method for producing a micronized, virtually anhydrous form of (1?,2?,4?,5?,7?)-7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide, said form per se, and the use thereof for producing a medicament, especially a medicament having an anticholinergic effect.Type: GrantFiled: December 7, 2006Date of Patent: October 13, 2015Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventors: Norbert Rasenack, Michael Walz, Michael Trunk, Hagen Graebner
-
Patent number: 9045776Abstract: The invention relates to DNA-sequences, especially transcription- or expression-enhancing elements (TE elements) and their use on an expression vector in conjunction with an enhancer, a promoter, a product gene and a selectable marker. TE elements bring about an increase in the expression of the product gene, particularly when stably integrated in the eukaryotic genome, preferably the CHO-DG44 genome.Type: GrantFiled: July 23, 2010Date of Patent: June 2, 2015Assignee: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KGInventors: Barbara Enenkel, Kerstin Sautter
-
Patent number: 9010323Abstract: An inhaler (1) includes a sieve part (9) for administrating powdered substances such as medical substances. The inhaler (1) includes a suction air channel (6) leading to a mouthpiece (4), a substance supply container (8) that is moveable inside a receiving chamber (7) and the sieve part (9) disposed in the suction air channel (6) between the receiving chamber (7) and the mouthpiece (4). The sieve part includes a retaining edge (10), a sieve area contained in a cross sectional area within the retaining edge (10), and a protruding area (12) that protrudes to one side and has a flat portion (13).Type: GrantFiled: March 11, 2009Date of Patent: April 21, 2015Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventors: Lukas Haerder, Claus Breuer
-
Patent number: 8975391Abstract: The invention concerns novel regulatory elements as well as related vectors and cells. Furthermore, it relates to methods of improving expression of polypeptides from nucleic acids such as cloned genes and to the production of various polypeptides in host cells using said novel regulatory elements. Additionally, the invention relates to uses of said novel regulatory elements as insulators, in gene therapy or for improving host cell lines.Type: GrantFiled: February 22, 2013Date of Patent: March 10, 2015Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventor: Barbara Enenkel
-
Patent number: 8969568Abstract: The invention relates to new substituted naphthyridines of formula 1, as well as pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof, wherein R1 is selected from among —O—R3 or —NR3R4, R3 is C1-6-alkyl which is substituted by R5 and R6, R5 is selected from hydrogen, branched or linear C1-6-alkyl, C2-6-alkenyl, —C1-6-alkylen-O—C1-3-alkyl, C1-3-haloalkyl, R6 is ring X wherein n is either 0 or 1, and is a either a single or a double bond and wherein A, B, D and E are each independently from one another selected from CH2, CH, C, N, NH, O or S and wherein ring X is attached to the molecule either via position A, B, D or E, wherein said ring X may optionally be further substituted by one, two or three residues each selected individually from the group consisting of -oxo, hydroxy, —C1-3-alkyl, —C1-3-haloalkyl, —O—C1-3-alkyl, —C1-3-alkanol and halogen, and wherein R4, R2, R7, R8, R9, R10, R11 and Q may have the meanings as given in claim 1, as welType: GrantFiled: January 26, 2011Date of Patent: March 3, 2015Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventors: Matthias Hoffmann, Georg Dahmann, Dennis Fiegen, Sandra Handschuh, Jasna Klicic, Guenter Linz, Gerhard Schaenzle, Andreas Schnapp, Stephen Peter East, Michael Philip Mazanetz, Robert John Scott, Edward Walker
-
Patent number: 8962312Abstract: The invention concerns the field of cell culture technology. The invention describes production host cell lines comprising vector constructs comprising a DHFR expression cassette. Those cell lines have improved growth characteristics in comparison to DHFR-deficient or DHFR-reduced cell lines such as CHO DG44 and CHO DUKX-B11. The invention especially concerns two cell lines, a representative of each cell line is deposited with the DSMZ under the number DSM ACC2909 (CHOpper® Discovery) and DSM ACC2910 (CHOpper® Standard). The invention further concerns a method of producing proteins using the cells generated by the described method.Type: GrantFiled: July 22, 2009Date of Patent: February 24, 2015Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventors: Hitto Kaufmann, Lore Florin, Eric Becker, Joey M. Studts
-
Publication number: 20140323732Abstract: The invention relates to a new process for preparing tiotropium salts of general formula 1 wherein X? may have the meanings given in the claims and in the specification.Type: ApplicationFiled: July 7, 2014Publication date: October 30, 2014Applicant: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KGInventors: Joerg BRANDENBURG, Waldemar PFRENGLE
-
Publication number: 20140286879Abstract: A pharmaceutical composition comprising: (a) a compound of formula 1 wherein: n is 1 or 2; R1 is hydrogen, halogen, C1-4-alkyl, or O—C1-4-alkyl; R2 is hydrogen, halogen, C1-4-alkyl, or O—C1-4-alkyl; and R3 is hydrogen, C1-4-alkyl, OH, halogen, O—C1-4-alkyl, O—C1-4-alkylene-COOH, or O—C1-4-alkylene-COO—C1-4-alkyl, or an enantiomer, mixture of enantiomers, or racemate thereof, or an acid addition salt with pharmacologically acceptable acids thereof, or a solvate or hydrate thereof; and (b) another active substance 2, wherein the molar ratio of the compound of formula 1 to the active substance 2 is 1:10 to 12:1.Type: ApplicationFiled: June 12, 2014Publication date: September 25, 2014Applicant: Boehringer Ingelheim Pharma GmbH & Co. KGInventors: Thierry BOUYSSOU, Michael Paul PIEPER, Andreas SCHNAPP
-
Patent number: 8739969Abstract: The invention relates to a folding box made from a one-piece cardboard blank (28) comprising an integrally formed hinged lid (7) that overlaps an upper end area of a rectangular-cuboid-shaped body (1) on three sides, is connected to a rear wall (5) of the body (1) through a fold line (6), and lies flush on a front wall (4) and two side walls (3) in the closed state, and having a front panel (9) and two side panels (10) that form a collar (11) that protrudes into the hinged lid (7), wherein the front panel (9) is arranged parallel to and at a distance from the front wall (4) and divides the body (1) into a main compartment (12) and a front compartment (13).Type: GrantFiled: January 30, 2013Date of Patent: June 3, 2014Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventor: Reinhard Schuld
-
Patent number: 8722694Abstract: The present invention relates to bicyclic heterocycles of general formula wherein Ra to Rc, A to E and X are defined as in claim 1, the tautomers, stereoisomers and salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases which have valuable pharmacological properties, in particular an inhibitory effect on signal transduction mediated by tyrosine kinases, their use in the treatment of diseases, especially tumoral diseases and diseases of the lungs and airways, and the preparation thereof.Type: GrantFiled: September 5, 2012Date of Patent: May 13, 2014Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventors: Frank Himmelsbach, Elke Langkopf, Thomas Metz, Flavio Solca, Birgit Jung, Anke Baum
-
Patent number: 8714151Abstract: An atomizing device (1), an inhaler and a method for dispensing a liquid formulation (5) are proposed. An insert (2) comprises a cylinder (4) filled with the liquid, an atomizing nozzle (7) and a piston (6). The piston is moved in the cylinder to pressurize the liquid and force it out of cylinder through the atomizing nozzle in order to generate a spray (13). The insert is received in a holder (3) which is sealed. The insert is moved within the holder so that the sealing (9) is ruptured before the spray is generated.Type: GrantFiled: January 16, 2009Date of Patent: May 6, 2014Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventor: Stephen T. Dunne
-
Publication number: 20140116435Abstract: An inhalation kit comprising: (a) an inhaler displaying a flow resistance of about 0.01 to 0.1, ?{square root over (kPa)} min/L; and (b) an inhalable powder comprising tiotropium in admixture with a physiologically acceptable excipient with an average particle size of between 10 to 500 ?m, and a method of administering an inhalable powder containing tiotropium in admixture with a physiologically acceptable excipient with an average particle size of between 10 pm to 500 ?m, the method comprising actuating an inhaler a flow resistance of about 0.01 to 0.1 ?{square root over (kPa)} min/L containing the inhalable powder.Type: ApplicationFiled: December 19, 2013Publication date: May 1, 2014Applicant: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KGInventor: Bernd ZIERENBERG
-
Publication number: 20140076308Abstract: A nozzle, an inhaler with a nozzle and a method for producing a nozzle are proposed. The nozzle comprises two holes formed in a flat plate. Then, the plate is deformed such that the axes of the holes intersect so that jets of fluids generated by the holes impinge with each other.Type: ApplicationFiled: November 13, 2013Publication date: March 20, 2014Applicant: Boehringer Ingelheim Pharma GmbH & Co. KGInventor: Stephen Terence DUNNE
-
Patent number: 8669109Abstract: A new method for selecting clones and recloning mammalian cells which are of importance for the production of biopharmaceuticals, preferably hamster or mouse myeloma cells, with a high degree of automation and throughput. The invention relates to methods of depositing and replicating single cell clones of the cells in question. The invention also relates to methods of preparing proteins using cells which have been obtained and replicated by single cell deposition as well as compositions which allow the replication of single cells.Type: GrantFiled: October 7, 2010Date of Patent: March 11, 2014Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventors: Ralf Otto, Barbara Enenkel, Juergen Fieder, Thomas Krieg